Immune Responses and Protective Efficacy of Nanoemulsion-Adjuvanted Monkeypox Virus Recombinant Vaccines Against Lethal Challenge in Mice
Congcong Zhang, Nuo Liu, Yanqi Zhao, Zhendong Pan, Dawei Wang, Wanda Tang, Yanhua He, Xu Zheng, Zhongtian Qi, Xinxin Zhang, Ping Zhao · 2025
Read Immune Responses and Protective Efficacy of Nanoemulsion-Adjuvanted Monkeypox Virus Recombinant Vaccines Against Lethal Challenge in Mice by Congcong Zhang, Nuo Liu, Yanqi Zhao, Zhendong Pan, Dawei Wang, Wanda Tang, Yanhua He, Xu Zheng, Zhongtian Qi, Xinxin Zhang, Ping Zhao (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735760.txt.
Description
The monkeypox outbreak that began in 2022 exposed the limits of the old smallpox-based vaccines. An eleven-author team built a cleaner alternative: a subunit vaccine using three monkeypox proteins, mixed with a nanoemulsion booster instead of living virus. They tested each protein alone and in pairs in mice, then challenged the animals with lethal doses.
All three single-protein vaccines protected every mouse against monkeypox. One protein, M1, gave the strongest protection and also guarded against a lethal vaccinia virus challenge, where the others failed. Two proteins produced antibodies that neutralize the virus in the lab; the third instead provoked a strong cell-based immune reply. A two-protein version with the nanoemulsion beat the same pairing with a classic alum booster on antibody levels and protection. The authors offer the comparison as groundwork for a safer human vaccine.
Catalog record
| CREATOR | Congcong Zhang, Nuo Liu, Yanqi Zhao, Zhendong Pan, Dawei Wang, Wanda Tang, Yanhua He, Xu Zheng, Zhongtian Qi, Xinxin Zhang, Ping Zhao |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |